Ieq Capital, LLC Incyte Corp Transaction History

Ieq Capital, LLC

$10.1 Billion
Q4 2024

A detailed history of Ieq Capital, LLC transactions in Incyte Corp stock. As of the latest transaction made, Ieq Capital, LLC holds 138,536 shares of INCY stock, worth $9.76 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

138,536

Previous 9,604 1342.48%

Holding current value

$9.76 Million

Previous $634,000 1409.15%

% of portfolio

0.09%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$65.08 - $83.38 $8.39 Million - $10.8 Million	128,932 Added 1342.48%	138,536 $9.57 Million
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $83,472 - $99,896	-1,456 Reduced 13.16%	9,604 $634,000
Q2 2024 Aug 12, 2024	BUY	$51.18 - $63.75 $180,716 - $225,101	3,531 Added 46.9%	11,060 $670,000
Q1 2024 May 08, 2024	BUY	$56.55 - $66.59 $31,159 - $36,691	551 Added 7.9%	7,529 $428,000
Q4 2023 Feb 07, 2024	BUY	$52.16 - $64.19 $33,486 - $41,209	642 Added 10.13%	6,978 $438,000
Q3 2023 Nov 03, 2023	BUY	$57.77 - $65.93 $75,736 - $86,434	1,311 Added 26.09%	6,336 $366,000
Q2 2023 Aug 07, 2023	SELL	$60.95 - $75.51 $192,967 - $239,064	-3,166 Reduced 38.65%	5,025 $312,000
Q1 2023 May 01, 2023	BUY	$70.23 - $86.01 $198,891 - $243,580	2,832 Added 52.85%	8,191 $591,000
Q4 2022 Feb 03, 2023	SELL	$67.18 - $84.11 $138,189 - $173,014	-2,057 Reduced 27.74%	5,359 $430,000
Q3 2022 Nov 03, 2022	SELL	$66.18 - $82.86 $37,590 - $47,064	-568 Reduced 7.11%	7,416 $494,000
Q2 2022 Jul 27, 2022	SELL	$66.18 - $83.18 $3,375 - $4,242	-51 Reduced 0.63%	7,984 $607,000
Q1 2022 Apr 26, 2022	BUY	$66.02 - $79.71 $88,136 - $106,412	1,335 Added 19.93%	8,035 $638,000
Q4 2021 Jan 31, 2022	BUY	$63.34 - $74.11 $209,402 - $245,007	3,306 Added 97.41%	6,700 $492,000
Q3 2021 Nov 09, 2021	BUY	$68.67 - $84.02 $11,330 - $13,863	165 Added 5.11%	3,394 $234,000
Q2 2021 Jul 29, 2021	BUY	$79.87 - $87.53 $39,375 - $43,152	493 Added 18.02%	3,229 $272,000
Q1 2021 May 04, 2021	BUY	$76.02 - $100.5 $207,990 - $274,968	2,736 New	2,736 $222,000
Q4 2020 Feb 03, 2021	SELL	$80.74 - $97.7 $199,266 - $241,123	-2,468 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$85.07 - $109.69 $43,811 - $56,490	515 Added 26.37%	2,468 $221,000
Q2 2020 Jul 31, 2020	BUY	$74.18 - $108.93 $144,873 - $212,740	1,953 New	1,953 $203,000

Others Institutions Holding INCY

# of Institutions

697

Shares Held

188M

Call Options Held

585K

Put Options Held

410K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.

Account